TALK KEYWORD INDEX
This page contains an index consisting of author-provided keywords.
| A | |
| acute and chronic rejection | |
| Acute leukemia | |
| acute lymphoblastic leukemia | |
| Acute myeloid leukemia | |
| acute rejection | |
| adaptive immune responses | |
| admixed population | |
| adoptive T-cell immunotherapy | |
| adverse drug reaction | |
| African ancestry | |
| ageing | |
| aGvHD | |
| AI & Big data transforming medical research | |
| Allocation | |
| Allogeneic Hematopoietic Cell Transplantation | |
| allogeneic hematopoietic stem cell transplantation | |
| allogeneic stem cell transplantation | |
| allograft rejection | |
| alloreactivity | |
| Analysis of MHC in Pangenome and thousand genome data | |
| ancestry | |
| Antiretroviral therapy | |
| Artificial intelligence | |
| Association | |
| autoimmune disease | |
| autoimmune diseases | |
| Autoimmunity | |
| B | |
| B cell memory | |
| B7H7 | |
| Best Abstract Awards | |
| Best Poster Awards | |
| big data | |
| Big Data Modeling | |
| bioethical regulation | |
| Bioinformatics | |
| biology of CD8+ Tregs | |
| biomarker | |
| Blood Groups | |
| BM microenvironment | |
| Bone Marrow Transplantation | |
| breast cancer | |
| BW4 | |
| C | |
| C4 | |
| Cancer Evolution | |
| CAR T-cell | |
| carbamazepine hypersensitivity | |
| Carcinoma cervix | |
| causative mechanisms | |
| CD4+ T cells | |
| CD8+ T cells | |
| cell therapy | |
| Cellular therapies | |
| Ceppellini Lecture | |
| cfDNA | |
| cGvHD | |
| chimerism | |
| Chimpanzee | |
| chimpanzees | |
| classical HLA alleles | |
| Closing Ceremony | |
| Closing Remarks | |
| CMV | |
| Committee meeting | |
| common diseases | |
| Complement Component 4 | |
| complex loci | |
| Copy Number Variation | |
| Cord Blood | |
| core permissive | |
| Coverage | |
| COVID-19 | |
| COVID-19 severity | |
| Cryptic immunopeptidome | |
| Crystal Structure | |
| Cytomegalovirus (CMV) | |
| D | |
| dd-cfDNA | |
| de novo assembly | |
| decidual immune cell | |
| Decision-making | |
| DEG | |
| Deletion | |
| differential expression | |
| disease association | |
| disease outcome | |
| diversity | |
| DNA | |
| donor-derived cell-free DNA | |
| droplet digital PCR | |
| DSA | |
| Duplication | |
| E | |
| EBMT | |
| Education | |
| EFI | |
| Epitope | |
| Eplet | |
| Epstein-Barr Virus | |
| ESOT | |
| European ancestry | |
| European collaborations ethical framework | |
| Evolution | |
| evolutionary divergence | |
| expression levels | |
| F | |
| French bioethics law | |
| Full-gene sequencing | |
| G | |
| Gene expression profile | |
| gene ontology | |
| gene regulatory networks | |
| Genetics bioethical regulation in France | |
| Genome wide survival study | |
| Genomic | |
| Genomic Organization | |
| Genotyping | |
| Genotyping array | |
| Graft biopsy | |
| graft-versus-host disease | |
| GVHD | |
| GWAS | |
| H | |
| Haematopoietic cell transplantation | |
| HAPLO-iPS | |
| haploidentical donor selection | |
| Haploidentical hematopoietic stemcell transplantation | |
| Haplotype | |
| HED | |
| hematopoietic cell transplantation | |
| hematopoietic stem cell transplantation | |
| heterologous immunity | |
| HHLA2 | |
| HIV | |
| HLA | |
| HLA association | |
| HLA Award | |
| HLA class I | |
| HLA class I epitopes | |
| HLA class II | |
| HLA E | |
| HLA evolutionary divergence | |
| HLA evolutionary divergence (HED) | |
| HLA immunogenicity | |
| HLA ligands | |
| HLA loss | |
| HLA matched related and unrelated donors | |
| hla matching | |
| HLA mismatch | |
| HLA molecular matching | |
| HLA*57:01 | |
| HLA-A*02:01 B*18:01 DRB*03 extended haplotype | |
| HLA-B | |
| HLA-Bw4 | |
| HLA-C | |
| HLA-DM | |
| HLA-DO | |
| HLA-DP | |
| HLA-DP binding motif | |
| HLA-DPB1 | |
| HLA-DPB1*13 | |
| HLA-DRB1 | |
| HLA-E | |
| Host genetic factors | |
| hsa-mir-7111-5p | |
| HSCT | |
| HSCT complications | |
| human cytomegalovirus | |
| Human Induced Pluripotent Stem Cells | |
| human populations | |
| human reference genome | |
| humoral immune responses | |
| humoral response | |
| I | |
| IEL | |
| IFN-α antibodies | |
| IHIWS | |
| IHIWS +365 Report | |
| imaging mass cytometry | |
| Immune diseases | |
| Immune diversity | |
| Immune escape | |
| immune pathways | |
| immune reconstitution | |
| Immune responses | |
| Immune system | |
| immune-mediated traits | |
| Immunogenecity | |
| Immunogenetic diversity | |
| Immunogenetics | |
| immunogenetics of ageing | |
| Immunogenicity | |
| immunoglobulin | |
| Immunology | |
| Immunopeptidome | |
| immunotherapies | |
| Immunotherapy | |
| impuatation | |
| Imputation | |
| Indirect allorecognition | |
| Infection | |
| Innovation in Transplantation | |
| J | |
| Jon Van Rood Award | |
| Julia Bodmer Award | |
| K | |
| Kidney pair donation | |
| Kidney Transplantation | |
| Killer cell immunoglobulin-like receptors | |
| KIR | |
| KIR association | |
| KIR gene organization | |
| KIR2DS4 | |
| KIR3DL2 | |
| KIR3DL3 | |
| L | |
| Leukemia relapse | |
| liquid biopsy | |
| liver transplantation | |
| lncRNAs | |
| Location of HLA-Y | |
| long read sequencing | |
| lung transplantation | |
| lupus | |
| M | |
| Macaque | |
| machine learning | |
| Major histocompatibility locus | |
| match | |
| matching | |
| memory cells | |
| memory HLA specificity | |
| MHC | |
| MHC Class I | |
| MHC diversity | |
| MHC evolution | |
| MICA | |
| Microbial Genomics | |
| microRNAs | |
| minor histocompatibility antigens | |
| Mismatches | |
| mRNA vaccine | |
| Multiple Myeloma | |
| Multiple Sclerosis | |
| Multivirus | |
| Myocarditis | |
| N | |
| naive T-cell depletion | |
| nanoporen | |
| Nanostring | |
| NAT | |
| Neanderthal Covid-19 risk haplotype | |
| New MHC class I sequence similar to HLA-P and HLA-W | |
| Next Generation Sequencing | |
| NGS | |
| NK | |
| NK cell diversity | |
| NK cells | |
| Non-classical HLA | |
| non-core permissive | |
| novel KIR alleles | |
| null allele | |
| O | |
| oocyte donation | |
| Opening Ceremony | |
| organ transplantation | |
| Oxford Nanopore Technologies sequencing | |
| P | |
| pairing algorithm | |
| Pan-European registries | |
| PANS | |
| Pediatric Acute-Onset Neuropsychiatric Syndrome | |
| pediatric heart transplantation | |
| peptide-binding | |
| Peptidome Analysis | |
| permissive mismatches | |
| Pfizer-BioNTech BNT162b2 vaccination | |
| PGAE | |
| philosophical analysis | |
| philosophy | |
| PIRCHE-II | |
| Plasmodium falciparum | |
| Polymorphism | |
| Population Frequency | |
| Population Genetics | |
| population groups | |
| population reference graph | |
| Population Structure | |
| post-transplant DSA treatment | |
| Post-Transplant Lymphoproliferative Disease | |
| pre-transplant desensitization | |
| Precision Medicine | |
| Prediction | |
| Promoter regions | |
| proteome | |
| R | |
| Recipient Specific Antibodies (RSA) | |
| Recombination | |
| Regulation | |
| Regulatory B cells | |
| Regulatory T cells | |
| Rejection | |
| relapse | |
| Renal transplantation | |
| Repertoire profiling | |
| Retrospecive study | |
| RNA | |
| RNA sequensing | |
| RNA-seq | |
| RPL | |
| S | |
| SARS-CoV-2 | |
| Scientific Committee | |
| Selection | |
| Sequence assembly | |
| Sequencing | |
| SFHI | |
| SHLARC | |
| SIP | |
| SMRT DNA sequencing | |
| software | |
| Solid Organ Transplantation | |
| Soluble HLA E | |
| spike | |
| stem cell transplantation | |
| Stem cells bioethical regulation in France | |
| survival analysis | |
| systemic autoimmune diseases | |
| systems immunology | |
| T | |
| T cell | |
| T cell receptor | |
| T cell receptor repertoire | |
| T cells | |
| T-cell epitope | |
| T-cell epitopes | |
| T-Cell Receptor Engineering | |
| T-cell receptors | |
| T-cell-mediated rejection | |
| TCR | |
| Telemedicine | |
| telomeres | |
| Tranplantation | |
| transcriptome | |
| Transgene expression | |
| Transmissible Cancer | |
| Transplantation | |
| Transplantation legal regulation in France | |
| tumor biology | |
| U | |
| unrelated donor | |
| V | |
| Vaccination | |
| Vaccine response | |
| Variant calling | |
| Variegated expression | |
| Viral infection | |
| Virological failure | |
| Virus specific T cell | |
| W | |
| Welcome Addresses | |
| whole genome sequencing | |
| γ | |
| γδ T cells | |